Story · Medicine & Biotech
FDA approves Imfinzi, Padcev for muscle invasive bladder cancer
3 outlets · first reported by FDA Drug Safety / Drugs feed on · latest · 4 hours of coverage
Editor’s note: This is a developing news story. Please check back soon for updates. The FDA approved a new treatment for muscle invasive bladder cancer: Imfinzi in combination with Padcev as a neoadjuvant treatment, followed by Imfinzi as adjuvant treatment after radical cystectomy. The treatment… (Healio)
Coverage, in order
-
FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer
FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer
-
FDA Approves Durvalumab Plus Enfortumab Vedotin for Muscle-Invasive Bladder Cancer
Auf YouTube findest du die angesagtesten Videos und Tracks. Außerdem kannst du eigene Inhalte hochladen und mit Freunden oder gleich der ganzen Welt teilen.
-
FDA approves Imfinzi, Padcev for muscle invasive bladder cancerEditor’s note: This is a developing news story. Please check back soon for updates. The FDA approved a new treatment for muscle invasive bladder cancer: Imfinzi in combination with Padcev as a neoadjuvant treatment, followed by Imfinzi as adjuvant treatment after radical cystectomy. The treatment…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.